Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant To Seek Review Of $425 Mil. Patent Suit Arbitration Award To Cordis

This article was originally published in The Gray Sheet

Executive Summary

Guidant stent sales will not be affected by a June 5 arbitration panel finding that the firm infringed Johnson &Johnson/Cordis' Palmaz-Schatz patents, Guidant says

You may also be interested in...



Cypher $470 Mil. Q4 Domestic Sales Double Size Of Cordis Unit

Cypher drug-eluting stent U.S. sales propelled a 99% Cordis revenue jump in the fourth quarter to $896 mil

Cypher $470 Mil. Q4 Domestic Sales Double Size Of Cordis Unit

Cypher drug-eluting stent U.S. sales propelled a 99% Cordis revenue jump in the fourth quarter to $896 mil

J&J/Cordis and Guidant arbitration

Ruling on Lau patent disputes, in which Guidant asserts infringement by Cordis' BX Velocity and Omni BX stents, is expected in early 2004. Guidant's Lau patent infringement claims against J&J/Cordis will be the second patent issue decided under the firms' April 2000 stent patent arbitration and cross-licensing deal. An Aug. 20 arbitration panel upheld a June decision to award J&J/Cordis $425 mil. for the infringement of its Palmaz-Schatz patents by Guidant's Multi-Link Duet coronary stent system (1The Gray Sheet" June 9, 2003, p. 22). Guidant set aside the money following the initial ruling and will incur no further costs due to the cross-licensing arrangement...

UsernamePublicRestriction

Register

OM006550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel